Trial · NCT04740931
Participant flow14
How many started, completed or left each group, period by period.
1 to 14 of 14
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part 1 (Baseline up to Week 24) | STARTED | Arm A: Faricimab Q4W (Part 1), Faricimab PTI (Part 2) | 366 | |
| Part 1 (Baseline up to Week 24) | STARTED | Arm B: Aflibercept Q4W (Part 1), Faricimab PTI (Part 2) | 363 | |
| Part 1 (Baseline up to Week 24) | Received at Least One Dose of Study Drug | Arm A: Faricimab Q4W (Part 1), Faricimab PTI (Part 2) | 365 | |
| Part 1 (Baseline up to Week 24) | Received at Least One Dose of Study Drug | Arm B: Aflibercept Q4W (Part 1), Faricimab PTI (Part 2) | 361 | |
| Part 1 (Baseline up to Week 24) | COMPLETED | Arm A: Faricimab Q4W (Part 1), Faricimab PTI (Part 2) | 360 | |
| Part 1 (Baseline up to Week 24) | COMPLETED | Arm B: Aflibercept Q4W (Part 1), Faricimab PTI (Part 2) | 353 | |
| Part 1 (Baseline up to Week 24) | NOT COMPLETED | Arm A: Faricimab Q4W (Part 1), Faricimab PTI (Part 2) | 6 | |
| Part 1 (Baseline up to Week 24) | NOT COMPLETED | Arm B: Aflibercept Q4W (Part 1), Faricimab PTI (Part 2) | 10 | |
| Part 2 (Week 24 to Week 72) | STARTED | Arm A: Faricimab Q4W (Part 1), Faricimab PTI (Part 2) | 360 | |
| Part 2 (Week 24 to Week 72) | STARTED | Arm B: Aflibercept Q4W (Part 1), Faricimab PTI (Part 2) | 353 | |
| Part 2 (Week 24 to Week 72) | COMPLETED | Arm A: Faricimab Q4W (Part 1), Faricimab PTI (Part 2) | 333 | |
| Part 2 (Week 24 to Week 72) | COMPLETED | Arm B: Aflibercept Q4W (Part 1), Faricimab PTI (Part 2) | 323 | |
| Part 2 (Week 24 to Week 72) | NOT COMPLETED | Arm A: Faricimab Q4W (Part 1), Faricimab PTI (Part 2) | 27 | |
| Part 2 (Week 24 to Week 72) | NOT COMPLETED | Arm B: Aflibercept Q4W (Part 1), Faricimab PTI (Part 2) | 30 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04740931/flow